| Name | Title | Contact Details |
|---|
Mission Statement Each day we make a personal commitment to go beyond - build deeper relationships, provide innovative solutions, work collaboratively as a team, serve our community, and be active stewards for the future of Glenn Burdette. Commitment to Service Accounting is often called a numbers business, but we view it as a service business. We are deeply committed to serving our clients, who are responsible for our success; our employees, who are the heart and soul of our firm; and our community, where we make our homes, raise our families and participate in activities that enrich our lives. Dedication to Clients Our goal is to go above and beyond for our clients, creatively applying our expertise and experience to meet their individual needs. We help them seize opportunities today, and offer solutions for their challenges ahead. We serve a diverse base of large, middle-market and small owner-managed businesses in a wide range of industries, and we are also proud to serve a number of nonprofit organizations, governmental agencies and individuals. Loyalty to Employees We foster an environment where hard work and client service are rewarded. In 2000, Glenn Burdette became the first CPA firm in California to become employee owned, developing an authentic investment in the professional development and personal success of our team. We believe that happy employees make the most satisfied clients. Involvement in Community Community service is integral to the culture of Glenn Burdette. Our employees serve on local nonprofit boards, and are active in chambers of commerce and service clubs from Santa Maria to Paso Robles.
Mechanics is a Ohio-based community bank that offers services including personal and business banking, trust, mortgages and loans for individuals and businesses.
Multimatic Inc. is a Canadian company founded in 1984 and based in Markham, Ontario. It specializes in providing automotive components, systems, complete vehicles, and engineering services on a global scale. With manufacturing and engineering facilities across North America, Europe, and Asia-Pacific, Multimatic has evolved from producing basic automotive parts to offering advanced vehicle dynamics and niche vehicle production. The company operates through several divisions, including Multimatic Mechanisms, which manufactures hinge systems and powered closures, and Multimatic Structures & Suspension, known for structural components and advanced suspension systems. Multimatic Engineering supports product development and manufacturing, while the Niche Vehicles division focuses on low-volume, high-performance sports cars. Additionally, Multimatic Motorsports designs and builds race cars, contributing to the companys engineering advancements. Multimatic collaborates with major automotive brands such as Ford, Honda, Volkswagen, and Aston Martin, providing innovative solutions and expertise in the automotive industry.
Zawyer Sports & Entertainment brings sports & your brand to life. Follow our family brands, Jacksonville Icemen, Community First Igloo, Savannah Ghost Pirates, Ghost Pirates Ice, Atlanta Gladiators, Allen Americans, Tahoe Knight Monsters, Gastonia Baseball Club, and 32 Degrees Marketing.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.